Join Us for November Spotlight Series: Effective Psychotropic Reduction in Post-Acute and Long-Term Care
Join Pathway Health and Advancing Excellence for the complimentary webinar “November Spotlight Series: Effective Psychotropic Reduction in Post-Acute and Long-Term Care on November 12, 2025, at 12:00 PM (ET).
About this Session:
This presentation will review how a large nursing home company systematically reduced their utilization of psychotropic medications and achieved a sustained Long-stay Antipsychotic QM rate of less than 12%. There will be a special focus on how to ensure regulatory compliance and accurate diagnoses while achieving this success. Participants will learn about this systematic approach and how to engage their facility to achieve similar results. There will be a focus on how to ensure regulatory compliance and accurate diagnoses while achieving this success.
When: November 12, 2025 | 12:00 PM (ET)
Session Objectives:
- Understand how to ensure regulatory compliance with psychotropic medications and associated diagnoses.
- Understand how an organization systematically reduced psychotropic medication utilization with sustained success.
- Understand the key roles of interdisciplinary team members in implementing a systematic approach to psychotropic medication reduction.
Panelists:
- Nancy Istenes, DO, CMD, FACP – Chief Medical Officer, Saber Healthcare Group
- Janeen Earwood, PT, CHC, WCC, CLT – VP Strategy and Analytics for Saber Healthcare Group
- Moderator: Jay Sackman, JD – Principal, Jay M. Sackman Consulting Services LLC
NOTE: This webinar is approved for Medical, Nursing and Administrator credits.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Post-Acute and Long-Term Care Medical Association and the Advancing Excellence in Long-Term Care Collaborative. Post-Acute and Long-Term Care Medical Association is accredited by the ACCME to provide continuing medical education for physicians. No one in control of content disclosed a relevant financial relationship with an ineligible company whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
